{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:38:01Z","timestamp":1792723081487,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1174405"],"award-info":[{"award-number":["GNT1174405"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["310640\/2017-2"],"award-info":[{"award-number":["310640\/2017-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.biopha.2020.111049","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T23:39:03Z","timestamp":1607038743000},"page":"111049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Unveiling six potent and highly selective antileishmanial agents via the open source compound collection \u2018Pathogen Box\u2019 against antimony-sensitive and -resistant Leishmania braziliensis"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1713-9474","authenticated-orcid":false,"given":"Juliano A.","family":"Souza Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7177-0059","authenticated-orcid":false,"given":"Luiza G.","family":"Tunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9204-0573","authenticated-orcid":false,"given":"Roney S.","family":"Coimbra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2948-2413","authenticated-orcid":false,"given":"David B.","family":"Ascher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3004-2119","authenticated-orcid":false,"given":"Douglas E.V.","family":"Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4688-2462","authenticated-orcid":false,"given":"Rubens L.","family":"Monte-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.111049_bib0005","unstructured":"WHO | Epidemiological situation, WHO. (n.d.). http:\/\/www.who.int\/leishmaniasis\/burden\/en\/ (accessed September 21, 2020)."},{"key":"10.1016\/j.biopha.2020.111049_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12727","article-title":"A spotlight on the diagnostic methods of a fatal disease Visceral Leishmaniasis","author":"Kumar","year":"2020","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.biopha.2020.111049_bib0015","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2478\/s11756-019-00360-6","article-title":"Identification of potential inhibitors targeted for strengthening search of anti-leishmanial therapeutics","volume":"75","author":"Jha","year":"2020","journal-title":"Biologia"},{"key":"10.1016\/j.biopha.2020.111049_bib0020","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1017\/S0031182016002523","article-title":"Chemotherapy of leishmaniasis: present challenges","volume":"145","author":"Uliana","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.biopha.2020.111049_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001827","article-title":"Open source drug discovery in practice: a case study","volume":"6","author":"\u00c5rdal","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2020.111049_bib0030","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/cmdc.201800755","article-title":"Unpacking the pathogen Box\u2014an open source tool for fighting neglected tropical disease","volume":"14","author":"Veale","year":"2019","journal-title":"ChemMedChem."},{"key":"10.1016\/j.biopha.2020.111049_bib0035","doi-asserted-by":"crossref","DOI":"10.1038\/415715a","article-title":"The medicines for malaria venture","volume":"415","author":"Hentschel","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2020.111049_bib0040","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00379-17","article-title":"Screening the medicines for malaria venture pathogen Box across multiple pathogens reclassifies starting points for open-source drug discovery","volume":"61","author":"Duffy","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2020.111049_bib0045","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijpddr.2016.07.004","article-title":"Screening of the \u2018Pathogen Box\u2019 identifies an approved pesticide with major anthelmintic activity against the barber\u2019s pole worm","volume":"6","author":"Preston","year":"2016","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.biopha.2020.111049_bib0050","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02006-16","article-title":"Screening the pathogen Box for identification of Candida albicans biofilm inhibitors","volume":"61","author":"Vila","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2020.111049_bib0055","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2147\/DDDT.S244903","article-title":"Leishmania donovani growth inhibitors from pathogen Box compounds of medicine for malaria venture","volume":"14","author":"Tadele","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.biopha.2020.111049_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008188","article-title":"Elucidating the possible mechanism of action of some pathogen box compounds against Leishmania donovani","volume":"14","author":"Amlabu","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2020.111049_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006639","article-title":"Development of NanoLuc-PEST expressing Leishmania mexicana as a new drug discovery tool for axenic- and intramacrophage-based assays","volume":"12","author":"Berry","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2020.111049_bib0070","doi-asserted-by":"crossref","unstructured":"S. Patterson, S. Wyllie, S. Norval, L. Stojanovski, F.R. Simeons, J.L. Auer, M. Osuna-Cabello, K.D. Read, A.H. Fairlamb, The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis, ELife. 5 (n.d.). https:\/\/doi.org\/10.7554\/eLife.09744.","DOI":"10.7554\/eLife.09744"},{"key":"10.1016\/j.biopha.2020.111049_bib0075","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1021\/acsinfecdis.0c00122","article-title":"An antiparasitic compound from the medicines for malaria venture pathogen Box Promotes leishmania tubulin polymerization","volume":"6","author":"Ullah","year":"2020","journal-title":"ACS infect. Dis."},{"key":"10.1016\/j.biopha.2020.111049_bib0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/cmdc.201200428","article-title":"Fueling open-source drug discovery: 177 small-molecule leads against tuberculosis","volume":"8","author":"Ballell","year":"2013","journal-title":"ChemMedChem."},{"key":"10.1016\/j.biopha.2020.111049_bib0085","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.biopha.2018.09.149","article-title":"Intraspecies susceptibility of Leishmania (Viannia) braziliensis to antileishmanial drugs: antimony resistance in human isolates from atypical lesions","volume":"108","author":"Rugani","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2020.111049_bib0090","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760190111","article-title":"Antimony resistance in Leishmania (Viannia) braziliensis clinical isolates from atypical lesions associates with increased ARM56\/ARM58 transcripts and reduced drug uptake","volume":"114","author":"Rugani","year":"2019","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.biopha.2020.111049_bib0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.biopha.2020.111049_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004660","article-title":"A luciferase-expressing leishmania braziliensis line that leads to sustained skin lesions in BALB\/c mice and allows monitoring of miltefosine treatment outcome","volume":"10","author":"Coelho","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2020.111049_bib0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0166-6851(00)00270-X","article-title":"Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. Infections in macrophages and in animal models","volume":"110","author":"Roy","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.biopha.2020.111049_bib0110","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2020.111049_bib0115","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng0506-500","article-title":"GenePattern 2.0","volume":"38","author":"Reich","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biopha.2020.111049_bib0120","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.biopha.2020.111049_bib0125","doi-asserted-by":"crossref","first-page":"W557","DOI":"10.1093\/nar\/gkw390","article-title":"CSM-lig: a web server for assessing and comparing protein-small molecule affinities","volume":"44","author":"Pires","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2020.111049_bib0130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jmb.2016.12.004","article-title":"Arpeggio: A Web Server for Calculating and Visualising Interatomic Interactions in Protein Structures","volume":"429","author":"Jubb","year":"2017","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.biopha.2020.111049_bib0135","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/prot.22639","article-title":"Detection of multiscale pockets on protein surfaces using mathematical morphology","volume":"78","author":"Kawabata","year":"2010","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"10.1016\/j.biopha.2020.111049_bib0140","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2020.111049_bib0145","doi-asserted-by":"crossref","first-page":"W32","DOI":"10.1093\/nar\/gku293","article-title":"SwissTargetPrediction: a web server for target prediction of bioactive small molecules","volume":"42","author":"Gfeller","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2020.111049_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2015.04.017","article-title":"In-vitro sensitivity of Pakistani Leishmania tropica field isolate against buparvaquone in comparison to standard anti-leishmanial drugs","volume":"154","author":"Jamal","year":"2015","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.biopha.2020.111049_bib0155","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1021\/acsinfecdis.9b00505","article-title":"Preclinical gold complexes as oral drug candidates to treat leishmaniasis are potent trypanothione reductase inhibitors","volume":"6","author":"Tunes","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.biopha.2020.111049_bib0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2020.111049_bib0165","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1002\/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U","article-title":"The Design of Leadlike Combinatorial Libraries","volume":"38","author":"Teague","year":"1999","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.biopha.2020.111049_bib0170","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1758-2946-1-8","article-title":"Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions","volume":"1","author":"Ertl","year":"2009","journal-title":"J. Cheminform."},{"key":"10.1016\/j.biopha.2020.111049_bib0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006157","article-title":"Discovery of novel, orally bioavailable, antileishmanial compounds using phenotypic screening","volume":"11","author":"Ortiz","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2020.111049_bib0180","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1016\/j.bmcl.2017.07.081","article-title":"Lead selection of antiparasitic compounds from a focused library of benzenesulfonyl derivatives of heterocycles","volume":"27","author":"Pagliero","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2020.111049_bib0185","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1128\/AAC.02398-12","article-title":"Comparison of a high-throughput high-content intracellular Leishmania donovani assay with an axenic amastigote assay","volume":"57","author":"De Rycker","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2020.111049_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001671","article-title":"An image-based high-content screening assay for compounds targeting intracellular Leishmania donovani amastigotes in human macrophages","volume":"6","author":"Siqueira-Neto","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.biopha.2020.111049_bib0195","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4269\/ajtmh.15-0448","article-title":"Antileishmanial activity of compounds derived from the medicines for malaria venture open access Box Against intracellular leishmania major amastigotes","volume":"94","author":"Khraiwesh","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.biopha.2020.111049_bib0200","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01640-17","article-title":"Discovery of new inhibitors of toxoplasma gondii via the pathogen Box","volume":"62","author":"Spalenka","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2020.111049_bib0205","doi-asserted-by":"crossref","first-page":"15913","DOI":"10.1074\/jbc.M108393200","article-title":"Purification and molecular characterization of cGMP-dependent protein kinase from apicomplexan parasites a NOVEL CHEMOTHERAPEUTIC TARGET","volume":"277","author":"Gurnett","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2020.111049_bib0210","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.molbiopara.2006.05.003","article-title":"Anticoccidial kinase inhibitors: identification of protein kinase targets secondary to cGMP-dependent protein kinase","volume":"149","author":"Donald","year":"2006","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.biopha.2020.111049_bib0215","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.bmcl.2013.01.010","article-title":"Chemical probes of a trisubstituted pyrrole to identify its protein target(s) in Plasmodium sporozoites","volume":"23","author":"Towle","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2020.111049_bib0220","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.exppara.2012.12.013","article-title":"Target specific-trisubstituted pyrrole inhibits Babesia bovis erythrocytic growth","volume":"133","author":"Lau","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.biopha.2020.111049_bib0225","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ijpara.2006.06.013","article-title":"Inhibitors of casein kinase 1 block the growth of Leishmania major promastigotes in vitro","volume":"36","author":"Allocco","year":"2006","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.biopha.2020.111049_bib0230","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11306-016-1062-1","article-title":"Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide","volume":"12","author":"Stoessel","year":"2016","journal-title":"Metabolomics"},{"key":"10.1016\/j.biopha.2020.111049_bib0235","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.molbiopara.2009.12.004","article-title":"Phospholipid and sphingolipid metabolism in Leishmania","volume":"170","author":"Zhang","year":"2010","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.biopha.2020.111049_bib0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025273","article-title":"CYP5122A1, a Novel Cytochrome P450 Is Essential for Survival of Leishmania donovani","volume":"6","author":"Verma","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2020.111049_bib0245","doi-asserted-by":"crossref","first-page":"6486","DOI":"10.1016\/j.bmcl.2008.10.075","article-title":"Imidazole pyrimidine amides as potent, orally bioavailable cyclin-dependent kinase inhibitors","volume":"18","author":"Jones","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2020.111049_bib0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073836","article-title":"Molecular basis of differential selectivity of cyclobutyl-substituted imidazole inhibitors against CDKs: insights for rational drug design","volume":"8","author":"Rath","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2020.111049_bib0255","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1016\/j.bmc.2016.07.069","article-title":"Discovery and antiparasitic activity of AZ960 as a Trypanosoma brucei ERK8 inhibitor","volume":"24","author":"Valenciano","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2020.111049_bib0260","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ijpara.2017.06.002","article-title":"In vitro screening of the open source Pathogen Box identifies novel compounds with profound activities against Neospora caninum","volume":"47","author":"M\u00fcller","year":"2017","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.biopha.2020.111049_bib0265","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1021\/jm500191u","article-title":"Pyridyl benzamides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei","volume":"57","author":"Ferrins","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2020.111049_bib0270","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cam4.175","article-title":"Identification of novel candidate compounds targeting TrkB to induce apoptosis in neuroblastoma","volume":"3","author":"Nakamura","year":"2014","journal-title":"Cancer Med."},{"key":"10.1016\/j.biopha.2020.111049_bib0275","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/joc.2004.16.1.3","article-title":"Antimicrobial dihydrofolate reductase inhibitors - achievements and future options: review","volume":"16","author":"Then","year":"2004","journal-title":"J. Chemother."},{"key":"10.1016\/j.biopha.2020.111049_bib0280","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1128\/AAC.00498-10","article-title":"Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system african trypanosomiasis","volume":"54","author":"Nare","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2020.111049_bib0285","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14574","article-title":"A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue","volume":"8","author":"Sonoiki","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2020.111049_bib0290","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4155\/fmc.11.80","article-title":"Benzoxaboroles: a new class of potential drugs for human African trypanosomiasis","volume":"3","author":"Jacobs","year":"2011","journal-title":"Future Med. Chem."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220312415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220312415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:51:34Z","timestamp":1792720294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220312415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":58,"alternative-id":["S0753332220312415"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.111049","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling six potent and highly selective antileishmanial agents via the open source compound collection \u2018Pathogen Box\u2019 against antimony-sensitive and -resistant Leishmania braziliensis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.111049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111049"}}